Taking key considerations into account along the cell therapy supply chain can set cell therapy developers up for success.
Joy Aho
Advertisement
Joy Aho is the senior project manager for Be The Match BioTherapies.
Articles by Joy Aho
Advertisement
Latest Updated Articles
Reducing Risk: Establishing Consistency and Scalability of Cell Therapy Starting MaterialPublished: April 1st 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
